| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Chemoradiation strategies for patients with malignant glioma
|
Curran Jr, Walter J.
|
|
1997
|
7 |
3S2 |
p. 33-36
4 p.
|
article
|
| 2 |
Chemotherapy and irradiation in locally advanced squamous cell carcinoma of the uterine cervix: A review
|
Perez, Carlos A.
|
|
1997
|
7 |
3S2 |
p. 45-65
21 p.
|
article
|
| 3 |
Clinical pharmacology of taxanes as radiosensitizers and the thiol-based radioprotectant amifostine
|
Dorr, Robert T.
|
|
1997
|
7 |
3S2 |
p. 66-76
11 p.
|
article
|
| 4 |
Combined modality therapy for esophageal cancer
|
Blanke, Charles D.
|
|
1997
|
7 |
3S2 |
p. 15-23
9 p.
|
article
|
| 5 |
Combined modality therapy for limited small cell lung cancer
|
Turrisi III, Andrew T.
|
|
1997
|
7 |
3S2 |
p. 8-14
7 p.
|
article
|
| 6 |
Combining radiation and chemotherapy: Current status and future directions
|
Choy, Hak
|
|
1997
|
7 |
3S2 |
p. 1-3
3 p.
|
article
|
| 7 |
Management of invasive bladder cancer: Strategies of combined modality treatment
|
Raghavan, Derek
|
|
1997
|
7 |
3S2 |
p. 37-44
8 p.
|
article
|
| 8 |
New agents with potential for radiation enhancement
|
Von Hoff, Daniel D.
|
|
1997
|
7 |
3S2 |
p. 82-86
5 p.
|
article
|
| 9 |
Paclitaxel and concurrent radiation for lung, pancreatic, and gastric carcinomas: Significance of p53 gene mutations for treatment response
|
Choy, Hak
|
|
1997
|
7 |
3S2 |
p. 77-81
5 p.
|
article
|
| 10 |
Pancreatic adenocarcinoma: Adjuvant, neoadjuvant, and intraoperative chemoradiation
|
Leach, Steven D.
|
|
1997
|
7 |
3S2 |
p. 24-32
9 p.
|
article
|
| 11 |
Therapy for locoregionally advanced head and neck cancer
|
Vokes, Everett E.
|
|
1997
|
7 |
3S2 |
p. 4-7
4 p.
|
article
|
Journal description